Evidence map›Paper›PMID 23256506›Full record

ArticleJournal of the American Chemical Society2013

Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamics.

Yuan-Hao Hsu, Denis Bucher, Jian Cao, Sheng Li, Sheng-Wei Yang, George Kokotos, Virgil L Woods, J Andrew McCammon, Edward A Dennis

Erratum issuedAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. The mechanism of allosteric regulation of calcium-independent phospholipase AProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. The PNPLA family of enzymes: characterisation and biological role.Arhiv za higijenu rada i toksikologiju · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  7. Phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  8. Article
  9. β-Lactones: A Novel Class of CaJournal of medicinal chemistry · 2019
    Article
  10. Article
  11. Article
  12. The structure of iPLANature communications · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Homologous ligands accommodated by discrete conformations of a buried cavity.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors.

Yuan-Hao HsuDepartment of Pharmacology, University of California, San Diego, La Jolla, California 92093-0601, USA. howardhsu@thu.edu.tw
Denis Bucher
Jian Cao
Sheng Li
Sheng-Wei Yang
George Kokotos
Virgil L Woods
J Andrew McCammon
Edward A Dennis

Funding

ACTION OF LIPOLYTIC ENZYMESR01GM020501 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 1985 to 2020
$7.3M
Current Generation Integrated Instrumentation for H-D Exchange LC-MSS10RR029388 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WOODS, VIRGIL L · 2010 to 2010
$1.0M
Sensitive Deuterium Exchange MS for Membrane ProteinsR01GM093325 · NIGMS · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI HANDEL, TRACY M, LEE, TERRY D. · 2010 to 2012
$965k
Howard Hughes Medical InstituteNCRR NIH HHS RR029388NCRR NIH HHS S10 RR029388NIGMS NIH HHS GM093325NIGMS NIH HHS R01 GM020501NIGMS NIH HHS R01 GM093325NIGMS NIH HHS R01-GM20501
6 · The paper itself

Abstract

The mechanism of inhibition of group VIA Ca(2+)-independent phospholipase A(2) (iPLA(2)) by fluoroketone (FK) ligands is examined by a combination of deuterium exchange mass spectrometry (DXMS) and molecular dynamics (MD). Models for iPLA(2) were built by homology with the known structure of patatin and equilibrated by extensive MD simulations. Empty pockets were identified during the simulations and studied for their ability to accommodate FK inhibitors. Ligand docking techniques showed that the potent inhibitor 1,1,1,3-tetrafluoro-7-phenylheptan-2-one (PHFK) forms favorable interactions inside an active-site pocket, where it blocks the entrance of phospholipid substrates. The polar fluoroketone headgroup is stabilized by hydrogen bonds with residues Gly486, Gly487, and Ser519. The nonpolar aliphatic chain and aromatic group are stabilized by hydrophobic contacts with Met544, Val548, Phe549, Leu560, and Ala640. The binding mode is supported by DXMS experiments showing an important decrease of deuteration in the contact regions in the presence of the inhibitor. The discovery of the precise binding mode of FK ligands to the iPLA(2) should greatly improve our ability to design new inhibitors with higher potency and selectivity.

Indexed as

Molecular Dynamics SimulationBinding SitesDeuterium Exchange MeasurementEnzyme InhibitorsGroup VI Phospholipases A2KetonesLigandsModels, MolecularMolecular StructureEnzyme InhibitorsGroup VI Phospholipases A2KetonesLigands

Identifiers

PMID23256506
PMCPMC3561773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.